Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7

Chemokine receptors play important roles in the immune system and are linked to several human diseases. Targeting chemokine receptors have so far shown very little success owing to, to some extent, the promiscuity of the immune system and the high degree of biased signaling within it. CCR7 and its t...

Full description

Bibliographic Details
Main Authors: Astrid S. Jørgensen, Olav Larsen, Edith Uetz-von Allmen, Michael Lückmann, Daniel F. Legler, Thomas M. Frimurer, Christopher T. Veldkamp, Gertrud M. Hjortø, Mette M. Rosenkilde
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02156/full
id doaj-adc9d50f5c624485a70b0f829f9929bd
record_format Article
spelling doaj-adc9d50f5c624485a70b0f829f9929bd2020-11-24T21:23:58ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-09-011010.3389/fimmu.2019.02156479458Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7Astrid S. Jørgensen0Olav Larsen1Edith Uetz-von Allmen2Michael Lückmann3Daniel F. Legler4Thomas M. Frimurer5Christopher T. Veldkamp6Gertrud M. Hjortø7Mette M. Rosenkilde8Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkBiotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, SwitzerlandThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, DenmarkBiotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, SwitzerlandThe Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, DenmarkDepartment of Chemistry, University of Wisconsin-Whitewater, Whitewater, WI, United StatesDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkDepartment of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkChemokine receptors play important roles in the immune system and are linked to several human diseases. Targeting chemokine receptors have so far shown very little success owing to, to some extent, the promiscuity of the immune system and the high degree of biased signaling within it. CCR7 and its two endogenous ligands display biased signaling and here we investigate the differences between the two ligands, CCL21 and CCL19, with respect to their biased activation of CCR7. We use bystander bioluminescence resonance energy transfer (BRET) based signaling assays and Transwell migration assays to determine (A) how swapping of domains between the two ligands affect their signaling patterns and (B) how receptor mutagenesis impacts signaling. Using chimeric ligands we find that the chemokine core domains are central for determining signaling outcome as the lack of β-arrestin-2 recruitment displayed by CCL21 is linked to its core domain and not N-terminus. Through a mutagenesis screen, we identify the extracellular domains of CCR7 to be important for both ligands and show that the two chemokines interact differentially with extracellular loop 2 (ECL-2). By using in silico modeling, we propose a link between ECL-2 interaction and CCR7 signal transduction. Our mutagenesis study also suggests a lysine in the top of TM3, K1303.26, to be important for G protein signaling, but not β-arrestin-2 recruitment. Taken together, the bias in CCR7 between CCL19 and CCL21 relies on the chemokine core domains, where interactions with ECL-2 seem particularly important. Moreover, TM3 selectively regulates G protein signaling as found for other chemokine receptors.https://www.frontiersin.org/article/10.3389/fimmu.2019.02156/fullligand biased signalingCCR7CCL21CCL19chemokine core domainECL2
collection DOAJ
language English
format Article
sources DOAJ
author Astrid S. Jørgensen
Olav Larsen
Edith Uetz-von Allmen
Michael Lückmann
Daniel F. Legler
Thomas M. Frimurer
Christopher T. Veldkamp
Gertrud M. Hjortø
Mette M. Rosenkilde
spellingShingle Astrid S. Jørgensen
Olav Larsen
Edith Uetz-von Allmen
Michael Lückmann
Daniel F. Legler
Thomas M. Frimurer
Christopher T. Veldkamp
Gertrud M. Hjortø
Mette M. Rosenkilde
Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
Frontiers in Immunology
ligand biased signaling
CCR7
CCL21
CCL19
chemokine core domain
ECL2
author_facet Astrid S. Jørgensen
Olav Larsen
Edith Uetz-von Allmen
Michael Lückmann
Daniel F. Legler
Thomas M. Frimurer
Christopher T. Veldkamp
Gertrud M. Hjortø
Mette M. Rosenkilde
author_sort Astrid S. Jørgensen
title Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
title_short Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
title_full Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
title_fullStr Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
title_full_unstemmed Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7
title_sort biased signaling of ccl21 and ccl19 does not rely on n-terminal differences, but markedly on the chemokine core domains and extracellular loop 2 of ccr7
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2019-09-01
description Chemokine receptors play important roles in the immune system and are linked to several human diseases. Targeting chemokine receptors have so far shown very little success owing to, to some extent, the promiscuity of the immune system and the high degree of biased signaling within it. CCR7 and its two endogenous ligands display biased signaling and here we investigate the differences between the two ligands, CCL21 and CCL19, with respect to their biased activation of CCR7. We use bystander bioluminescence resonance energy transfer (BRET) based signaling assays and Transwell migration assays to determine (A) how swapping of domains between the two ligands affect their signaling patterns and (B) how receptor mutagenesis impacts signaling. Using chimeric ligands we find that the chemokine core domains are central for determining signaling outcome as the lack of β-arrestin-2 recruitment displayed by CCL21 is linked to its core domain and not N-terminus. Through a mutagenesis screen, we identify the extracellular domains of CCR7 to be important for both ligands and show that the two chemokines interact differentially with extracellular loop 2 (ECL-2). By using in silico modeling, we propose a link between ECL-2 interaction and CCR7 signal transduction. Our mutagenesis study also suggests a lysine in the top of TM3, K1303.26, to be important for G protein signaling, but not β-arrestin-2 recruitment. Taken together, the bias in CCR7 between CCL19 and CCL21 relies on the chemokine core domains, where interactions with ECL-2 seem particularly important. Moreover, TM3 selectively regulates G protein signaling as found for other chemokine receptors.
topic ligand biased signaling
CCR7
CCL21
CCL19
chemokine core domain
ECL2
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02156/full
work_keys_str_mv AT astridsjørgensen biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT olavlarsen biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT edithuetzvonallmen biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT michaelluckmann biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT danielflegler biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT thomasmfrimurer biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT christophertveldkamp biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT gertrudmhjortø biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
AT mettemrosenkilde biasedsignalingofccl21andccl19doesnotrelyonnterminaldifferencesbutmarkedlyonthechemokinecoredomainsandextracellularloop2ofccr7
_version_ 1725990247978762240